< Back to companies

Abridge

The one conversation that matters.

Abridge is an AI-powered platform that automatically generates structured clinical notes from patient-physician conversations. Using generative AI, it listens ambiently to the conversation and creates a real-time, accurate summary in the required format for the electronic health record (EHR), saving doctors hours of administrative work each day.

Share
Shareable draft
Get Involved in Abridge

How We Help

Only accessible to MedStartr community members. Join now

Problem Statement

Physician burnout is a crisis, largely driven by the overwhelming burden of clinical documentation. Doctors spend more time on paperwork than with patients, leading to exhaustion, errors, and a decline in the quality of care. Existing solutions are often clunky and don't fit naturally into the patient-physician conversation.

Core Technology

Generative AI for Clinical Documentation

Key Differentiators

Focus on ambient, conversational AI that integrates seamlessly into the clinical workflow. Proprietary dataset from over 200,000 clinical encounters. Real-time note generation and structuring. Backed by major health systems and top-tier VCs.

Clinical Focus

Primary Care, Specialty Care

Target Customers

Hospitals, Health Systems, large physician groups.

Product Stage

GA

Company Info

Business Model
B2B2C
Total Funding
Only accessible to MedStartr community members. Join now

Categories

Clinical Documentation

Disease Areas

Technologies

EHR IntegrationMachine LearningNLPSpeech RecognitionGenerative AIAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Abridge's technology is built on a proprietary dataset from more than 200,000 clinical encounters. Their AI is continuously trained and evaluated by medical professionals to ensure accuracy. They have demonstrated a 99%+ accuracy rate in identifying medical terms and medications. A study published in the New England Journal of Medicine Catalyst showed Abridge saved clinicians over 3 hours per week on average.

🛡️

IP Protection

Patents Pending

Only accessible to MedStartr community members. Join now

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Sign in to join the conversation.

Sign in to comment
Be the first to comment.

What do you think of Abridge?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Abridge
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free